Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synera in Carpal Tunnel Syndrome
NCT00991068Phase 2Completed
- Sponsor
- ZARS Pharmaceuticals
- Start
- Sep 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetracaine in carpal tunnel syndrome (CTS), sponsored by ZARS Pharmaceuticals. Started Sep 2009; status: completed.
02
Drugs
tetracaine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT00991068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00991068.